{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:36Z","timestamp":1786997916546,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.urolonc.2009.06.018","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T02:21:11Z","timestamp":1272853271000},"page":"338-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["BCAN Think Tank session 3: Prevention of bladder cancer"],"prefix":"10.1016","volume":"28","author":[{"given":"Seth P.","family":"Lerner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Barton","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Kibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Parnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret G.","family":"House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2009.06.018_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00345-006-0123-x","article-title":"Chemoprevention of bladder cancer","volume":"24","author":"Golijanin","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2009.06.018_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jnci\/91.8.675","article-title":"Annual report to the nation on the status of cancer, 1973\u20131996, with a special section on lung cancer and tobacco smoking","volume":"91","author":"Wingo","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2009.06.018_bib3","first-page":"83","article-title":"A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands)","volume":"13","author":"Zeegers","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2009.06.018_bib4","first-page":"143","article-title":"New treatments for smoking cessation","volume":"50","author":"Hughes","year":"2000","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2009.06.018_bib5","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.288.14.1768","article-title":"Effective tobacco dependence treatment","volume":"288","author":"Fiore","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2009.06.018_bib6","series-title":"Treating tobacco use and dependence: 2008 update in clinical practice guideline","author":"Fiore","year":"2008"},{"key":"10.1016\/j.urolonc.2009.06.018_bib7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ijc.2910450604","article-title":"Vitamin A supplements, fried foods, fat, and urothelial cancer. A case-referent study in Stockholm in 1985\u201387","volume":"45","author":"Steineck","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2009.06.018_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/93.8.597","article-title":"Methods to improve efficacy of intravesical mitomycin c: Results of a randomized phase III trial","volume":"93","author":"Au","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2009.06.018_bib9","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11095-007-9298-0","article-title":"Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel","volume":"24","author":"Tsai","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.urolonc.2009.06.018_bib10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/1535-7163.MCT-06-0545","article-title":"Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-\u03baB and nuclear factor-\u03baB-regulated gene products in IFN-\u03b1-sensitive and IFN-\u03b1-resistant human bladder cancer cells","volume":"6","author":"Kamat","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urolonc.2009.06.018_bib11","doi-asserted-by":"crossref","unstructured":"Sabichi AL, Lerner SP, Grossman HB, et al. Retinoids in the chemoprevention of bladder cancer. Curr Opin Oncol 2998;10:479\u201384.","DOI":"10.1097\/00001622-199809000-00019"},{"key":"10.1016\/j.urolonc.2009.06.018_bib12","doi-asserted-by":"crossref","unstructured":"Sabichi AL, Lerner SP, Atkinson EN, et al. Phase III prevention trial of fenretinide in patients with resected non-muscle invasive bladder cancer. Clin Cancer Res 1008;14:224\u20139.","DOI":"10.1158\/1078-0432.CCR-07-0733"},{"issue":"Suppl 4","key":"10.1016\/j.urolonc.2009.06.018_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-5347(08)61713-9","article-title":"Multicenter randomized comparison of BCG with or without Interferon\u03b12b (IFN) and oncovite (ONC) vs. recommended daily allowance (RDA) vitamins during induction and extended 3-week maintenance","volume":"179","author":"Lamm","year":"2008","journal-title":"J Urol"},{"issue":"Suppl 4","key":"10.1016\/j.urolonc.2009.06.018_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(09)60208-1","article-title":"Results of a Phase II\/IIIg trial of celecoxib to prevent recurrence of non-muscle invasive bladder cancer","volume":"181","author":"Lerner","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.06.018_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-5347(18)35078-X","article-title":"A randomized prospective phase III trial of difluoromethylornithine (DFMO) vs. placebo (P) in preventing recurrence of completely resected low risk superficial bladder cancer","volume":"173","author":"Messing","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2009.06.018_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJMoa075819","article-title":"Cumulative association of five genetic variants with prostate cancer","volume":"58","author":"Zheng","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143909002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143909002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:55:53Z","timestamp":1761040553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143909002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1078143909002002"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2009.06.018","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCAN Think Tank session 3: Prevention of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2009.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}